|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004083,
umls-concept:C0032854,
umls-concept:C0040648,
umls-concept:C0152018,
umls-concept:C0521447,
umls-concept:C0683598,
umls-concept:C1274040,
umls-concept:C1521761,
umls-concept:C1559154,
umls-concept:C1561558,
umls-concept:C1879547
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-2-10
|
|
pubmed:abstractText |
The lack of effective treatment for localized esosphageal cancer leads to poor patient outcome. Nuclear factor kappaB (NF-kappaB), a transcriptional factor, is constitutively activated or treatment induced in esophageal cancer and may influence treatment outcomes.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AggarwalBharat BBB,
pubmed-author:AjaniJaffer AJA,
pubmed-author:ChaoK S CliffordKS,
pubmed-author:EnsorJoeJ,
pubmed-author:HittelmanWalter NWN,
pubmed-author:IzzoJulie GJG,
pubmed-author:LeeJeffrey HJH,
pubmed-author:LiaoZhongxingZ,
pubmed-author:LuthraRajyalakshmiR,
pubmed-author:MalhotraUshaU,
pubmed-author:SwisherStephen GSG,
pubmed-author:WuTsung-TehTT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
10
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
748-54
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16401681-Adult,
pubmed-meshheading:16401681-Aged,
pubmed-meshheading:16401681-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16401681-Camptothecin,
pubmed-meshheading:16401681-Carcinoma,
pubmed-meshheading:16401681-Combined Modality Therapy,
pubmed-meshheading:16401681-Disease-Free Survival,
pubmed-meshheading:16401681-Esophageal Neoplasms,
pubmed-meshheading:16401681-Female,
pubmed-meshheading:16401681-Fluorouracil,
pubmed-meshheading:16401681-Gene Expression Profiling,
pubmed-meshheading:16401681-Humans,
pubmed-meshheading:16401681-Immunohistochemistry,
pubmed-meshheading:16401681-Infusions, Intravenous,
pubmed-meshheading:16401681-Injections, Intravenous,
pubmed-meshheading:16401681-Male,
pubmed-meshheading:16401681-Middle Aged,
pubmed-meshheading:16401681-NF-kappa B,
pubmed-meshheading:16401681-Neoplasm Invasiveness,
pubmed-meshheading:16401681-Neoplasm Staging,
pubmed-meshheading:16401681-Prognosis,
pubmed-meshheading:16401681-Taxoids,
pubmed-meshheading:16401681-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma.
|
|
pubmed:affiliation |
Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
